Back to Search
HANINA HIBSHOOSH, M.D.
M.D.
Anatomic Pathology Physician
NPI: 1730216821IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
168982-1(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
NEW YORK MEDICAL COLLEGE
Class of 1985
Research & Publications (20)
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
PMID 19602588·Cancer Res·2009
7-preclinical
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.
PMID 19174523·Proc Natl Acad Sci U S A·2009
7-preclinical
Mutations in p53, p53 protein overexpression and breast cancer survival.
PMID 19602056·J Cell Mol Med·2009
8-other
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
PMID 18339845·Cancer Res·2008
8-other
Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
PMID 18406867·Cancer Genet Cytogenet·2008
4-observational
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
PMID 18066063·Nat Genet·2008
7-preclinical
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.
PMID 18408767·Oncogene·2008
7-preclinical
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
PMID 17452630·Proc Natl Acad Sci U S A·2007
8-other
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy.
PMID 16896931·Cancer Chemother Pharmacol·2007
5-case
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
PMID 17197928·Am J Surg Pathol·2007
4-observational
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
PMID 17210525·Am J Clin Pathol·2007
8-other
CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
PMID 16890615·Gastroenterology·2006
4-observational
Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.
PMID 16341153·Mod Pathol·2006
8-other
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
PMID 15805248·Cancer Res·2005
8-other
Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
PMID 15827818·Ann Surg Oncol·2005
4-observational
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.
PMID 15867227·Clin Cancer Res·2005
4-observational
Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review.
PMID 15911928·Integr Cancer Ther·2005
6-review
Invasive ductal carcinoma with fibrotic focus: mammographic and sonographic findings with histopathologic correlation.
PMID 16037526·AJR Am J Roentgenol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 622 W 168TH ST, PH1564W
NEW YORK, NY 10032 - Phone
- (212) 305-7399
Quick Facts
- NPI
- 1730216821
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile